Ethosuximide induced agranulocytosis

Brain and Development

Volumn 25, Issue 7, 2003, Pages 522-524

  Imai, Tadashi ^a   Okada, Hitoshi ^a   Nanba, Masanori ^a   Kawada, Kou ^a   Kusaka, Takashi ^a   Itoh, Susumu ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

Agranulocytosis; Down syndrome; Drug induced lymphocyte stimulation test; Ethosuximide

Indexed keywords

ANTIBIOTIC AGENT; ETHOSUXIMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; NITRAZEPAM; PHENOBARBITAL; VALPROIC ACID;

AGRANULOCYTOSIS; ANAMNESIS; ARTICLE; ARTIFICIAL VENTILATION; BLOOD EXAMINATION; BONE MARROW BIOPSY; CASE REPORT; CHILD; EPILEPSY; GRANULOCYTE; HUMAN; LEUKOCYTE COUNT; MALE; PNEUMONIA;

EID: 0345304757     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0387-7604(03)00060-3     Document Type: Article

References (11)

1. Julia A., Olona M., Bueno J., Revilla E., Rossello J., Petit J., et al. Drug-induced agranulocytosis: prognostic factors in a sereies of 168 episodes. Br J Haematol. 79:1991;366-371.
2. Harvey R.A., Champe P.C., Mycer M.J. Drugs used to treat epilepsy. Lippincott's illustrated reviews: pharmacology. 1992;143-150 JB Lippincott Co, Philadelphia.
3. Yamamoto T., Pipo J.R., Akaboshi S., Narai S. Forced normalization induced by ethosuximide therapy in a patient with intractable myoclonic epilepsy. Brain Dev. 23:2001;62-64.
4. Kaufman DW, Kelley JP, Levy M, Shapiro S. The drug etiology of agranulocytosis and aplastic anemia. Oxford, 1991; 148-58 Oxford University Press.
5. Boxer L.A. Leukopenia. Behrman R.E., Kliegman R.M., Jenson H.B. Nelson textbook of pediatrics. 2000;621-626 Saunders, Philadelphia.
6. Massey G.V., Dunn N.L., Heckel J.L., Myer E.C., Russell E.C. Aplastic anemia following therapy for absence seizures with ethosuximide. Pediatr Neurol. 11:1994;59-61.
7. Seip M. Aplastic anemia during ethosuximide medication. Acta Pediatr Scand. 72:1983;927-929.
8. Spittler J.F. Ethosuxmide-bedingte Agranulozytose mit letalem Ausgang. Klin Pädiat. 186:1974;364-366.
9. Cuadrado E., Barrena M.J. Immune dysfunction in Down's syndrome: primary immune deficiency or early senescence of the immune system? Clin Immunol Immunopathol. 78:1996;209-214.
10. Salama A., Mueller-Eckhardt C. Immune-mediated blood cell dyscrasias related to drugs. Semin Hematol. 29:1992;54-63.
11. Mylonakis E., Akhtar M.S., Lopez F., Hussain S.I., Chen J.L., Koutkia P., et al. Resolution of drug-induced agranulocytosis. Geriatrics. 55:2000;89-91.